Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$11,325,019
+$2,433,603 QoQ
Shares Held
9,442
-2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.67%
of 13F equity value
Holder Rank
#1,190
of 4,605 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Radnor Capital Management, LLC holds $105,731,738 across 8 Drug Manufacturers - General names. LLY ranks #2 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
518,900 | $66,678,650 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
9,442 | $11,325,019 | |
| 3 | JNJ |
Johnson & Johnson
|
42,628 | $10,826,233 | |
| 4 | ABBV |
AbbVie Inc.
|
28,539 | $7,181,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,233 | $4,565,405 | |
| 6 | AMGN |
Amgen Inc
|
6,596 | $2,388,543 | |
| 7 | PFE |
Pfizer Inc
|
77,621 | $1,869,113 | |
| 8 | NVS |
Novartis AG
|
5,725 | $897,222 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,325,019 | 9,442 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $8,891,416 | 9,667 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $10,388,932 | 9,667 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $7,635,341 | 10,007 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $7,917,686 | 10,157 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $8,388,767 | 10,157 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $7,825,764 | 10,137 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $10,906,807 | 12,311 | Shares | Sole | 2024-10-30 | |
| 2024-03-31 | $8,196,586 | 10,536 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $6,272,802 | 10,761 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $5,780,593 | 10,762 | Shares | Sole | 2023-10-12 | |
| 2023-03-31 | $2,294,389 | 6,681 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $1,698,229 | 4,642 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,502,930 | 4,648 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,627,634 | 5,020 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,520,624 | 5,310 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,369,498 | 4,958 | Shares | Sole | 2022-01-20 | |
| 2021-06-30 | $1,243,998 | 5,420 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,104,106 | 5,910 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $997,844 | 5,910 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $852,595 | 5,760 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $994,930 | 6,060 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $868,387 | 6,260 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||